A US biotech company has received federal approval to start the world’s first study of stem cells for treatment of spinal cord injury. Dr. Thomas Okarma, president and CEO of Geron Corp. of Menlo Park, California declared that 10 paraplegic patients will be injected with cells derived from embryonic cells.